跳至主要内容
临床试验/NCT01361672
NCT01361672已完成不适用

Attain Ability® Family Left Ventricular Lead Chronic Performance Study

Medtronic0 个研究点目标入组 1,140 人开始时间: 2011年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Medtronic
入组人数
1,140
主要终点
Model 4296 LV Lead-related complication rate

研究概览

简要总结

Lead survivability will be summarized.

详细描述

The purpose of this study is to evaluate long-term performance of the 4296 LV Lead. This evaluation is based on the number of lead-related complications occurring during the study compared to the number of leads enrolled in the study. The leads will be followed for 5 years after implant. This study is required by FDA as a condition of approval of the Model 4296 LV Lead. This study is conducted within Medtronic's post-market surveillance platform.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Model 4296 LV Lead-related complication rate

时间窗: 5 years

To demonstrate that the Model 4296 lead-related complication-free probability

次要结局

  • Types of lead-related adverse device effects(5 years)
  • Percent of subjects with changes in electrode programming(5 years)
  • Number of fractures with and without loss of function(5 years)
  • Bipolar electrical performance at 1 year(1 year)
  • Bipolar pacing impedance(1 year)
  • Bipolar pacing capture threshold(1 year)

研究者

发起方
Medtronic
申办方类型
Industry
责任方
Sponsor

相似试验